Disorder of pilosebaceous unit
MONDO:0002917A disease that involves the pilosebaceous unit.
Also known as: disease of pilosebaceous unit, disease or disorder of pilosebaceous unit, disorder of pilosebaceous unit, hair and hair follicle diseases, hair disorder, hair/hair follicle diseases, pilosebaceous unit disease, pilosebaceous unit disease or disorder
341 clinical trials for this condition and its sub-types, 7 tagged with Disorder of pilosebaceous unit itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disorder of pilosebaceous unit
-
Hair anomaly 0 trials · 228 incl. sub-types
8 sub-types
- Alopecia 130 trials · 225 incl. sub-types Sub-types →
- Pili bifurcati 2 trials
- Ringed hair disease 1 trial
- Isolated familial wooly hair disorder 0 trials Sub-types →
- Pili gemini 0 trials
- Pili torti 0 trials
- Trichodysplasia-xeroderma syndrome 0 trials
- Uncombable hair syndrome 0 trials Sub-types →
-
Sebaceous gland disorder 0 trials · 101 incl. sub-types
7 sub-types
- Acne 92 trials Sub-types →
- Internal hordeolum 1 trial · 6 incl. sub-types Sub-types →
- Sebaceous gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Alopecia mucinosa 0 trials
- Demodicidosis of sebaceous gland 0 trials
- Rhinophyma 0 trials
- Sebocystomatosis 0 trials
-
Folliculitis 1 trial · 8 incl. sub-types
4 sub-types
- Demodex folliculitis 5 trials
- Acne keloid 1 trial
- Eosinophilic pustular folliculitis 1 trial Sub-types →
- Sycosis barbae 0 trials
-
Hypotrichosis 5 trials · 6 incl. sub-types
19 sub-types
- Hypotrichosis of eyelid 2 trials
- Basaran Yilmaz syndrome 0 trials
- Marie Unna hereditary hypotrichosis 0 trials Sub-types →
- Congenital hypotrichosis milia 0 trials
- Congenital hypotrichosis with juvenile macular dystrophy 0 trials
- Hypotrichosis 1 0 trials
- Hypotrichosis 10 0 trials
- Hypotrichosis 11 0 trials
- Hypotrichosis 12 0 trials
- Hypotrichosis 13 0 trials
- Hypotrichosis 14 0 trials
- Hypotrichosis 15 0 trials
- Hypotrichosis 16 0 trials
- Hypotrichosis 2 0 trials
- Hypotrichosis 3 0 trials
- Hypotrichosis 6 0 trials
- Hypotrichosis 7 0 trials
- Hypotrichosis 8 0 trials
- Hypotrichosis 9 0 trials
-
Piedra 0 trials · 2 incl. sub-types
3 sub-types
- White piedra 2 trials
- Black piedra 0 trials
- Endothrix infectious disease 0 trials
-
Hair follicle neoplasm 0 trials
3 sub-types
- Follicular infundibulum tumor 0 trials
- Pilomatrixoma 0 trials
- Proliferating trichilemmal cyst 0 trials
-
Hypertrichosis 0 trials
11 sub-types
- Rabson-Mendenhall syndrome 0 trials
- Acquired hypertrichosis lanuginosa 0 trials
- Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome 0 trials
- Cataract-hypertrichosis-intellectual disability syndrome 0 trials
- Cervical hypertrichosis-peripheral neuropathy syndrome 0 trials
- Gingival fibromatosis-hypertrichosis syndrome 0 trials
- Hypertrichosis cubiti-short stature syndrome 0 trials
- Hypertrichosis lanuginosa congenita 0 trials Sub-types →
- Hypertrichosis of eyelid 0 trials Sub-types →
- Hypertrichosis-acromegaloid facial appearance syndrome 0 trials
- Isolated anterior cervical hypertrichosis 0 trials
-
Trichostasis spinulosa 0 trials
Most studied deeper sub-types
-
New drug aimed at regrowing hair in severe alopecia
Disease control Stopped earlyThis study tested a drug called amlitelimab in 166 adults with severe alopecia areata, a condition causing significant hair loss. Participants received either the drug or a placebo by injection. The main goal was to see if the drug could reduce hair loss scores after 36 weeks. Th…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Exosome hair loss study halted early – what we know
Disease control Stopped earlyThis study tested whether exosomes from donated stem cells could help people with hair loss. It was a small, early-phase trial with 16 participants, comparing treated areas to untreated ones. The study was terminated early, so results are limited. The goal was to see if the treat…
Early phase 1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control Stopped earlyThis study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hair loss ointment study halted early – only 4 people enrolled
Disease control Stopped earlyThis study tested a custom ointment called DPCP to help people with severe alopecia areata, a condition causing patchy or complete scalp hair loss. The goal was to see if the ointment could safely regrow hair. Only 4 people took part before the study was stopped early, so results…
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Light therapy for stubborn eyelid lumps? tiny trial ends early
Disease control Stopped earlyThis study tested whether intense pulsed light (IPL) can help treat chalazion, a common eyelid lump. Only 4 adults with a fresh chalazion were enrolled, and the trial was stopped early. Because of the very small size, we cannot say if IPL works or is safe for this condition.
Sponsor: Lumenis Be Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Cream combo tested for scalp bumps in men of african descent
Disease control Stopped earlyThis study tested Duobrii, a prescription cream that combines a strong steroid with a retinoid, for treating early-mild acne keloidalis nuchae (AKN) — a chronic scalp condition causing bumps and scarring, mainly in men of African descent. The trial planned to enroll 15 adults wit…
Phase 3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gut bacteria supplement tested against chemo hair loss
Symptom relief Stopped earlyResearchers are testing a synbiotic formula called BLHK03 to see if it can reduce hair loss caused by chemotherapy in women with breast cancer. The trial includes 7 women with stage I to III breast cancer who are scheduled for chemotherapy with anthracycline or taxane drugs. Part…
Sponsor: GenieBiome Limited • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
WaterPik for your head? study tests scalp massager for flakes and hair loss
Symptom relief Stopped earlyThis study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Laser zaps acne? small trial fizzles out
Symptom relief Stopped earlyThis study tested whether a fractional carbon dioxide laser can improve moderate to severe acne in adults aged 18 to 40. Participants received up to 3 laser treatments and were followed for changes in blemish count and skin severity. The trial was terminated early and only enroll…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can a laser make hair grow? small study tests skin rejuvenation for bald spots
Symptom relief Stopped earlyThis study tested whether a laser treatment used for skin rejuvenation could help grow hair in people with alopecia (hair loss) on the scalp. Only 5 people were enrolled before the study was stopped early. Each person had half their scalp treated with a laser and the other half l…
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Hair loss hope? supplement tested in men, but study stopped early
Symptom relief Stopped earlyThis study tested a dietary supplement made from plant extracts to see if it could help men aged 40 to 65 with thinning hair. The trial was planned to last 9 months and involved 155 men, but it was terminated early. Researchers aimed to measure hair growth and quality compared to…
Sponsor: Nutraceutical Wellness Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC